Search Editorial Photos
"Shinopharm"
628 professional editorial images found
#6789362
8 Jun 2021
A health worker prepares to inoculate a dose of the Vero cell COVID-19 vaccine in Kathmandu, Nepal on Tuesday, June 8, 2021. After receiving 1 million doses of the COVID-19 vaccine from china, the Nepal government has continued vaccination for the 60-64 age groups.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6789364
8 Jun 2021
Nepalese people line up to receive a dose of the Vero cell COVID-19 vaccine in Kathmandu, Nepal on Tuesday, June 8, 2021. After receiving 1 million doses of the COVID-19 vaccine from china, the Nepal government has continued vaccination for the 60-64 age groups.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6789366
8 Jun 2021
Nepalese people line up to receive a dose of the Vero cell COVID-19 vaccine in Bhaktapur, Nepal on Tuesday, June 8, 2021. After receiving 1 million doses of the COVID-19 vaccine from china, the Nepal government has continued vaccination for the 60-64 age groups.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6789368
8 Jun 2021
Nepalese people wait after receiving a dose of the Vero cell COVID-19 vaccine in Bhaktapur, Nepal on Tuesday, June 8, 2021. After receiving 1 million doses of the COVID-19 vaccine from china, the Nepal government has continued vaccination for the 60-64 age groups.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6789370
8 Jun 2021
A health worker inoculates a dose of the Vero cell COVID-19 vaccine in Bhaktapur, Nepal on Tuesday, June 8, 2021. After receiving 1 million doses of the COVID-19 vaccine from china, the Nepal government has continued vaccination for the 60-64 age groups.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6789372
8 Jun 2021
A health worker prepares to inoculate a dose of the Vero cell COVID-19 vaccine in Bhaktapur, Nepal on Tuesday, June 8, 2021. After receiving 1 million doses of the COVID-19 vaccine from china, the Nepal government has continued vaccination for the 60-64 age groups.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6789374
8 Jun 2021
A health worker prepares to inoculate a dose of the Vero cell COVID-19 vaccine in Bhaktapur, Nepal on Tuesday, June 8, 2021. After receiving 1 million doses of the COVID-19 vaccine from china, the Nepal government has continued vaccination for the 60-64 age groups.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6789376
8 Jun 2021
A Nepalese woman sanitizes her hands as she arrives to receive a dose of the Vero cell COVID-19 vaccine in Bhaktapur, Nepal on Tuesday, June 8, 2021. After receiving 1 million doses of the COVID-19 vaccine from china, the Nepal government has continued vaccination for the 60-64 age groups.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6789378
8 Jun 2021
Nepalese people wait after receiving a dose of the Vero cell COVID-19 vaccine in Bhaktapur, Nepal on Tuesday, June 8, 2021. After receiving 1 million doses of the COVID-19 vaccine from china, the Nepal government has continued vaccination for the 60-64 age groups.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6789380
8 Jun 2021
A man arrives to receive a dose of Vero cell COVID-19 vaccine in Bhaktapur, Nepal on Tuesday, June 8, 2021. After receiving 1 million doses of the COVID-19 vaccine from china, the Nepal government has continued vaccination for the 60-64 age groups.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6789382
8 Jun 2021
A health worker inoculates a dose of the Vero cell COVID-19 vaccine in Bhaktapur, Nepal on Tuesday, June 8, 2021. After receiving 1 million doses of the COVID-19 vaccine from china, the Nepal government has continued vaccination for the 60-64 age groups.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11567303
12 Sep 2024
The Sinopharmate Group office building is seen in Shanghai, China, on September 12, 2024.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11567304
12 Sep 2024
The Sinopharmate Group office building is seen in Shanghai, China, on September 12, 2024.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#7998500
31 Mar 2022
A young kid hold by his mother is vaccinated with a dose of Sinopharm COVID-19 vaccine at the walk-in vaccination center in Lima city center. in Lima city center. On Wednesday, March 30, 2022, in Lima, Peru.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#7998498
31 Mar 2022
A young kid hold by his mother is vaccinated with a dose of Sinopharm COVID-19 vaccine at the walk-in vaccination center in Lima city center. in Lima city center. On Wednesday, March 30, 2022, in Lima, Peru.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#7998496
31 Mar 2022
A young kid hold by his mother is vaccinated with a dose of Sinopharm COVID-19 vaccine at the walk-in vaccination center in Lima city center. in Lima city center. On Wednesday, March 30, 2022, in Lima, Peru.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.